$CTIX Company News Cellceutix Brilacidin IND effective,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CTIX Company News

Cellceutix Brilacidin IND effective, Phase 2 to begin 9:31 a.m. Oct. 13, 2014 - Seeking Alpha
Regulatory Support Creates Opportunity For Antibiotic Makers Otonomy And Cellceutix 9:02 a.m. Sept. 25, 2014 - Seeking Alpha
Update: Cellceutix Calls Out To President Obama About Brilacidin 2:38 p.m. Sept. 21, 2014 - Seeking Alpha
10-K: CELLCEUTIX CORP 12:53 p.m. Sept. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol 2:06 a.m. Sept. 14, 2014 - Seeking Alpha
The Antibiotic Resistance Triple Threat 1:05 p.m. Sept. 4, 2014 - Seeking Alpha
Cellceutix completes enrollment in Brilacidin trial 8:45 a.m. Aug. 19, 2014 - Seeking Alpha
Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market? 10:38 a.m. Aug. 14, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 9:15 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix 9:34 a.m. April 25, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 4:09 p.m. Feb. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin 9:31 a.m. Jan. 28, 2014 - Seeking Alpha
Cellceutix Corp.: A Biotech With High Risk But High Reward 3:17 p.m. Jan. 2, 2014 - Wall St. Cheat Sheet
Cellceutix: An Undiscovered Company Set To Rise In 2014 9:06 a.m. Dec. 16, 2013 - Seeking Alpha
3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference 5:38 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: CELLCEUTIX CORP 5:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: CELLCEUTIX CORP 3:01 p.m. Sept. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: CELLCEUTIX CORP 1:18 p.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
Interview with CEO of Cellceutix Corporation: Leo Ehrlich 8:57 a.m. Nov. 15, 2011 - GuruFocus.com

Cellceutix's New Chief Operating Officer Dr. James Alexander Addresses Shareholders 6:00 a.m. Oct. 31, 2014 - Marketwired
Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable to 7-Days of Daptomycin 10:52 a.m. Oct. 23, 2014 - Marketwired
Cellceutix Investigational New Drug (IND) Application Becomes Effective, Selects First Site for Phase 2 Clinical Trial of New Treatment for Oral Mucositis 8:02 a.m. Oct. 13, 2014 - Marketwired
Cellceutix Provides Update to Shareholders 11:30 a.m. Sept. 24, 2014 - Marketwire
Cellceutix to President Obama: We Have the Tools and Will Rise Up to the Challenge to Prevent Antibiotic Resistant Bacteria Becoming a Serious Threat to Public Health 6:15 a.m. Sept. 19, 2014 - Marketwire
Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application to FDA for Phase 2 Trial of Brilacidin-OM for Oral Mucositis 2:01 p.m. Sept. 9, 2014 - Marketwire
Cellceutix to Present at Rodman & Renshaw's 16th Annual Global Investment Conference 10:17 a.m. Sept. 5, 2014 - Marketwire
Cellceutix Appoints Dr. Barry Schechter to Board of Directors as Company Focuses on Meeting Requirements for Stock Exchange Uplisting 6:01 a.m. Sept. 2, 2014 - Marketwire
Cellceutix Completes Enrollment in Phase 2b Clinical Trial of Brilacidin for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 7:31 a.m. Aug. 19, 2014 - Marketwire
Cellceutix Prepares for Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis 6:01 a.m. Aug. 11, 2014 - Marketwire
Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial 5:04 a.m. Aug. 8, 2014 - Marketwire
Cellceutix Believes Brilacidin on Track to Help U.S. Avoid Falling Into Post-Antibiotic Era; Completion of Enrollment in Phase 2b Trial for Acute Bacterial Skin and Skin Structure Infections Expected This Month 6:01 a.m. Aug. 4, 2014 - Marketwire
Cellceutix Announces Breakthrough in the Formulation of Its Novel Antibiotic Brilacidin(TM), Plans Studies to Treat Diabetic Foot Ulcers 6:01 a.m. July 14, 2014 - Marketwire
Cellceutix Brilacidin ABSSSI Trial Gets Positive Review by Data Safety Monitoring Board; Best Possible Outcome, No Treatment-Related Serious Adverse Events (SAEs) 6:00 a.m. July 7, 2014 - Marketwire
Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant 6:01 a.m. June 23, 2014 - Marketwire
Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort 6:01 a.m. June 16, 2014 - Marketwire
Cellceutix Completes Patient Enrollment in Clinical Trial of Prurisol 6:02 a.m. June 2, 2014 - Marketwire
Cellceutix Signs Material Transfer Agreements for Defensin Mimetic Compounds With Leading Universities 6:02 a.m. May 27, 2014 - Marketwire
Cellceutix Plans for Entry in Diabetic Foot Wound and Ulcer Market 6:01 a.m. May 19, 2014 - Marketwire
Cellceutix Confident in Its Formidable Antibiotic Arsenal 6:01 a.m. May 12, 2014 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PlugClaw: TrustKernel's AI Gadget Tackles Privacy Hurdles

Updated Category News Views 2

A Handy Revolution in AI Computing You know, every now and then, a gadget shows up that flips the scene on its head. Enter TrustKernel's PlugClaw. It's not every day you see a whole computer in something barely the size of your thumb, yet this one does exactly that. Weighing in at a measly 15 grams and armed with a MediaTek Helio G80, we're looking at a USB-C stick that's...

Continue Reading
Restaurant Industry Bolsters Safety with New Guide

Updated Category News Views 2

There’s a fresh playbook hitting the shelves, and it’s aimed at the heart of the dining world—a guide that tackles the nasty curveballs of public safety incidents. Restaurants, the places we count on for warm meals and cold drinks, aren’t just about what’s on the menu; they're about keeping folks safe, too. The National Restaurant Association just dropped a new...

Continue Reading
CreditRefresh's AI Tackles 1,000+ Disputes Launch Month

Updated Category News Views 2

AI-Powered Revolution in Credit Disputes Alright, here we are staring down the latest twist in the credit game. CreditRefresh, an AI-driven platform out of Dover, Delaware, has managed to kickstart its journey by challenging over 1,000 credit report errors in just its first month on the market. That's quite a sprint straight from the gate, don't you think? But hey, this...

Continue Reading
Tetragon Completes $50M Tender Offer; Shares Prorated

Updated Category News Views 1

Unpacking Tetragon’s $50 Million Dutch Auction Move If you comb through the smoke-filled corridors of finance, you'll find the name Tetragon Financial Group pacing the latest tender offer rounds. They danced their way through a $50 million 'modified Dutch auction,' snapping up non-voting shares with a kind of ruthless efficiency that only seasoned market players can...

Continue Reading
ACEMAGIC Unveils New AI Mini Workstation at IFA 2026

Updated Category News Views 2

A Glimpse Into ACEMAGIC's Latest Innovation Look if you had told me five years ago that AI mini workstations would be making waves, I'd have probably smirked. Yet, here we are; ACEMAGIC is setting the stage at IFA 2026 in Berlin with their fresh-out-the-oven F9A AI mini workstation, powered by AMD's Ryzen AI Max+ PRO 495 processor. It all goes down from September 4 to 8...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 2

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
Safety and Wellbeing as Key Business Strategy Focus

Updated Category News Views 2

Revolutionizing Safety in the Workplace Cracking the typical mindset of treating employee safety as a checkbox item, Debra Wein, CEO and Founder of Wellness Workdays, is set to shake up the NSC Safety Congress & Expo. Her upcoming session, titled "Transforming Safety and Wellbeing into a Competitive Business Advantage," isn't just a run-of-the-mill talk. It's a call to...

Continue Reading
JIMMY's Nespure N9: Innovating Coffee and Clean Water

Updated Category News Views 2

Unpacking JIMMY's Latest Innovation at IFA Every now and then, something comes along that makes you think, "Why didn't I think of that?" Well, JIMMY just hit that nail square on the head with its latest concoction—the Nespure N9. Debuting at the IFA 2026 in Berlin, this little gizmo combines water purification with coffee brewing, all from a modestly-sized countertop...

Continue Reading
CHiQ's AI Blitz: Local Touch Amplifies Global Reach

Updated Category News Views 0

A New Era for Home Appliances You ever walk into your kitchen and wonder why your fridge can't just figure out how you like your veggies sorted? Well, as of September 4, 2026, CHiQ, this somewhat maverick in consumer electronics, showed up at the IFA in Berlin with a new arsenal of AI-infused gadgets. Don't yawn just yet—these gizmos aren't just about cramming in tech...

Continue Reading
AARP New York Promotes Affordable 'Staycation' Experiences

Updated Category News Views 2

Exploring New York Without Breaking the Bank Tough times call for creative solutions, and AARP New York is on the ball. With travel costs soaring and many older New Yorkers scrimping to make ends meet, the 'Staycation' campaign steps in with an offer too good to pass up: uncovering the gems of New York right under our noses without shelling out hefty sums. The plan? Turn...

Continue Reading

Top 5 Most Recently Viewed Articles

Sobi's Innovations in Rare Disease Treatments Highlighted at EAHAD

Updated Category News Views 198

Introducing Sobi's Commitment to the Haemophilia Community Swedish Orphan Biovitrum AB (publ) (Sobi) is thrilled to announce its participation in the 19th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD). This event, held in February 2026, promises to be a significant platform for sharing knowledge and advancing treatments for...

Continue Reading
Esquire Financial Holdings, Inc. Announces New Headquarters Facility

Updated Category News Views 214

Esquire Financial Holdings, Inc. Expands Headquarters Esquire Financial Holdings, Inc. (NASDAQ: ESQ), a prominent financial holding company, has announced an exciting development in its corporate structure. The company has secured a new headquarters lease that promises to significantly enhance its operational capabilities. This new office is located at 300 Jericho...

Continue Reading
Masitinib's Potential in Treating Progressive Multiple Sclerosis

Updated Category News Views 197

AB Science's Role in Neurodegenerative Research AB Science has been at the forefront of developing innovative treatments for serious neurological conditions, with a keen focus on diseases like multiple sclerosis. One of their most promising compounds, masitinib, has garnered attention in the medical community. Understanding Masitinib Masitinib is a protein kinase...

Continue Reading
The Growing Demand for 4-Wheel Mobility Scooters Explained

Updated Category News Views 238

Overview of the 4-Wheel Mobility Scooters Market The market for 4-wheel mobility scooters is on an impressive trajectory, with estimates predicting it will exceed USD 2.2 billion in valuation within the next several years. This growth reflects a significant demand driven by an aging global population and a rising prevalence of mobility-related issues. Shifting Trends in...

Continue Reading
Tesla's Groundbreaking Robotaxi Event Showcases Autonomous Innovation

Updated Category News Views 141

Tesla Showcases Autonomous Driving at the 'We, Robot' Event Tesla Inc. (NASDAQ: TSLA) recently held an impressive event highlighting their ongoing advancements in autonomous driving technology. It was an innovative gathering where attendees could experience the capabilities of the company's robotaxis, particularly the newly unveiled Cybercab, designed for complete...

Continue Reading